Agoracom Blog Home

Posts Tagged ‘$TSXV’

Namaste Announces Record Breaking Sales of C$1.34M Representing 21.8% Month-On-Month Increase $N.ca

Posted by AGORACOM-JC at 8:49 AM on Monday, July 10th, 2017

Nlogo

  • Achieved record monthly sales and traffic for the month of June
  • Total unaudited sales as reported by the Company were C$1,349,545 in June 2017
  • Compared to C$1,108,034 in May 2017, a 21.8% increase.

VANCOUVER, British Columbia, July 10, 2017 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has achieved record monthly sales and traffic for the month of June. The total unaudited sales as reported by the Company (including shipping revenues and after discounts and refunds) were C$1,349,545 in June 2017 compared to C$1,108,034 in May 2017, a 21.8% increase.

The month-on-month increase in revenue was achieved across the large network of sites operated by Namaste which all showed higher conversion rates. The increase in revenue is particularly pleasing as typically revenue is soft during the summer months. Namaste Vapes and Everyonedoesit showed good progress in conversion rates and average order value which were drivers of revenue growth. Australian Vaporizers benefited from an already high conversion rate which increased to 4.5% for the month.

The table below displays a revenue breakdown for Namaste’s various sales channels.

Revenues – June 2017 (C$)
Channels   6,942
Distribution Goods   143,437
Dropshipping   18,972
EDIT   191,500
Green Vapes   17,273
Namaste   547,459
Australian Vaporizers   423,961
Total revenues     1,349,545
Below are gross sales of the major sites operated by the Company. Revenues below do not include shipping revenues and are before discounts and refunds.
Selected operating data e-Commerce June 2017 in C$    
  traffic conversion orders  basket price  gross revenues
Namaste 94,139 1.96 % 1,845 $   278 $   513,827
Australian Vaporizers 45,040 4.50 % 2,026 $   182 $   367,766
EDIT 247,717 0.87 % 2,148 $   94 $   201,134
GreenVapes 3,479 1.47 % 51 $   303 $   15,469
Total   390,375 1.55 %   6,070 $    181 $    1,098,195

Namaste has implemented proprietary machine learning algorithms on several of its major sites that adjust website content and product listings ‘on-the-fly’ based on user behavior. These sites have seen substantial increases in conversion rates as a result and Namaste plans on launching the same technology throughout their platform.

At the end of June the Company granted 1,725,000 options to staff and consultants. The options will vest quarterly over a period of two years and are exercisable for five years at an exercise price of $0.25.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We’re very excited to see amazing results in June sales due to of all the hard work from our management team in implementing innovative strategies to increase sales organically. The implementation of machine learning to our platform has had immediate positive results. We expect to see similar results once this technology is launched throughout our platform. We look forward to continued growth as well as expansion into new markets and product categories.”

About Namaste Technologies Inc.

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Contact:
Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastevapes.com

Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals $TBP.ca

Posted by AGORACOM-JC at 9:05 AM on Wednesday, July 5th, 2017

Tbp large

  • Strengthened its position on bringing marijuana to patients in the form of a prescription drug
  • Has become a world leader in the field of cannabis drug development and its PPP001 dried cannabis drug was covered in the Global Pain Management Drugs Market analysis report published by Azoth Analytics in May 2017

OTTAWA, ONTARIO–(July 5, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug. Tetra has become a world leader in the field of cannabis drug development and its PPP001 dried cannabis drug was covered in the Global Pain Management Drugs Market analysis report published by Azoth Analytics in May 2017. According to this report, Tetra is the only company developing dried marijuana as a drug.

One in five Canadians will live with pain in their lifetime and one in two will be affected by cancer. Canadian courts have ruled in favor of patients wanting access to marijuana for relief. In response to these decisions, the Canadian government has implemented the Access to Cannabis for Medical Purposes Regulations (ACMPR) to help bring marijuana to patients. Canada’s Prime Minister has been very favorable in bringing marijuana to patients but it will be up to corporations to step in and adhere to the Canadian Food and Drug regulations to bring marijuana medications to patients. Tetra is a world leader in the drug development field of cannabis-based medications and is paving the road to become the first company to commercialize a dried marijuana product as a drug in North America.

“Canadian’s are entitled to access to marijuana to treat their pain or its co-morbidities. It is not a question of social standing or a judgement if the act of ‘smoking’ is acceptable for patients. It is a fundamental right to have access to a botanical drug that can effectively allow patients to have a better quality of life,” commented Dr. Guy Chamberland, CSO of Tetra Bio-Pharma. “There is sufficient evidence suggesting that smoking marijuana is an adequate medication to help relieve pain and improve a patient’s well-being. Both of these are important aspects to offering effective therapies to patients. The challenge has been addressing quality and safety issues to meet the standards of a drug.”

Over the years our society has inherited an image that ‘smoking’ or ‘vaporizing’ is not associated with a healthy approach to health care. According to the expert committee on the Health Effects of Marijuana (National Academies Press, 2017), ‘smoking cannabis does not increase the risk for certain cancers (i.e., lung, head and neck)’. In addition, cancer patients typically consume an amount of dried marijuana per day, in dry weight, that is less than 1 tobacco cigarette, without the paper, per day. The significantly reduced amount of smoke per day is one of the explanations supporting that smoking marijuana does not increase the risk for these cancers. That said, these are effective routes of delivering a complex botanical medication. “Society has to focus on caring for all patients living with pain not just those that want a different dosage form,” commented Dr. Chamberland. He added, “In fact our challenge is to characterize the safety and efficacy of this therapy, ensure lot-to-lot quality, provide adequate risk information to health professionals, demonstrate the safety and efficacy so that physicians can adequately assess the potential efficacy and safety for their patient, and actively pursue more tolerable dosage forms to offer these innovative cannabis therapies to patients. In the end, a patient’s desire to smoke marijuana for relief has to be defended by Canadian courts and politicians. We live in a democratic society and we have to care for everyone.”

“Tetra undertook the development of PPP001 as a first prescription marijuana drug. The company is preparing its phase 3 trial in cancer patients and will assess the safety and efficacy using both the titanium pipe and vaporizer delivery systems. From Day 1, Tetra was dedicated to characterizing the safety and tolerability of consuming medical marijuana by smoking. Tetra also adopted the firm position of working transparently with regulators because the corporation believed it is important to bring marijuana, as traditionally used, to patients. Tetra will continue to work with provincial and federal governments, including physician and pharmacist professional corporations, to help address issues associated with the development and commercialization of a first prescription medical marijuana drug.”

“Tetra already works closely with Health Canada through the regulatory processes in place for the development of drugs and controlled substances,” commented Dr. Chamberland. He added that, “Tetra was working closely with the province of New Brunswick whom from Day 1 was very active in preparing for the eventual legalization of marijuana in Canada. Tetra is working with physician and pharmacist professional associations/corporations and will be working closely with these health professionals as the company prepares for its Phase 3 trial and the eventual commercialization of the first dried marijuana drug.”

“Tetra has performed safety, pharmacokinetic and cognitive function studies in healthy volunteers. The corporation has characterized the safety of consuming marijuana and understands what the potential risks are to consumers and patients. This information will be made available by Tetra to Health Canada and to other government departments on request. We believe that this safety data provides a clear and accurate picture of what happens to people that smoke marijuana recreationally,” commented Dr. Chamberland. “We believe it is our responsibility to provide this information to regulators to help pave the road for the Trudeau government’s legalization.”

In addition, Tetra will use its clinical knowledge from its Phase 1 and Safety clinical studies to implement effective and secure patient care programs. This includes working with independent professional organizations to transfer its clinical risk information and ensure that these groups provide continued medical education to their health professionals. Dr. Chamberland commented, “Launching the first dried marijuana drug in Canada brings a responsibility of ensuring that all safety risks are communicated to health professionals to ensure the well-being of consumers. No body wants another fentanyl-type crisis; all we want is for patients to obtain relief and an improved quality of life when consuming marijuana that is of the same quality as any other prescription medication.”

“Tetra will be actively pursuing the development and commercialization of PPP001 to remain a world leader in the field of cannabis medicine,” commented Andre Rancourt, CEO of Tetra Bio-Pharma. “We are dedicated to working with distributors and pharmaceutical companies interested in bringing medical marijuana as a prescription drug around the world. We are focusing on bringing to patients what the Supreme Court of Canada ruled was their right: access to marijuana.”

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
(514) 360-8040 Ext. 203
edward@tetrabiopharma.com

Excavator Program Exposes Vein over 160 Meters Multiple Showings of Visible Gold on the Gold Drop Property Historic Gold Camp Greenwood BC $GGX.ca

Posted by AGORACOM-JC at 10:32 AM on Tuesday, July 4th, 2017

  • Excavator Program Exposes Vein over 160 Meters Multiple Showings of Visible Gold
  • Trenching program has now doubled the size of exposed Vein from 80 meters as reported in the June 15th News Release to 160 Meters and it appears to continue along strike

Vancouver, British Columbia (FSCwire)GGX Gold Corp. (TSXV: GGX) (the “Company” or “GGX”) is pleased to announce its excavator trenching program has now doubled the size of exposed Vein from 80 meters as reported in the June 15th News Release to 160 Meters and it appears to continue along strike. The vein is located in the Gold Drop Southwest Zone. As well the company is continuing to channel sample the newly exposed area. The company plans to begin a drilling program shortly and has spotted the first 15 holes along the newly exposed Vein. Drill pads are being constructed and discussions have been underway with contractors.

 

To view the graphic in its original size, please click here

 

The company also would like to report that there have been multiple locations were visible Gold has been spotted in bedrock throughout the property. As such the company is currently in the process of increasing security in various locations in and around the property with Wireless cameras and fencing.

 

To view the graphic in its original size, please click here

 

To view the graphic in its original size, please click here

 

The Gold Drop property covers geologically prospective ground in the well-mineralized Greenwood Mining Division. The property hosts numerous low-sulfide, gold and silver bearing quartz veins or vein systems, four of which were previously mined (Gold Drop, North Star, Amandy and Roderick Dhu veins).

 

To view the graphic in its original size, please click here

June 2017 Trenching at Gold Drop Southwest Zone (area of historic C.O.D shaft)

 

David Martin, P.Geo., a Qualified Person as defined by NI 43-101, is responsible for the technical information contained in this News Release.

 

On Behalf of the Board of Directors,

 

Barry Brown, Director

 

604-488-3900

 

Forward Looking Information

 

This news release includes certain statements that constitute “forward-looking information” within the meaning of applicable securities law, including without limitation, the Company’s information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed transactions. Forward-looking statements address future events and conditions and are necessarily based upon a number of estimates and assumptions. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Forward-looking statement are necessarily based upon several factors that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements express or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of gold and other metals, anticipated costs and the ability to achieve goals, and the Company will be able to obtain required licenses and permits. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks including that resource exploration and development is a speculative business; that environmental laws and regulations may become more onerous; that the Company may not be able to raise additional funds when necessary; fluctuating prices of metals; the possibility that future exploration, development or mining results will not be consistent with the Company’s expectations; operating hazards and risks; and competition. There can be no assurance that economic resources will be discovered or developed at the Gold Drop Property. Accordingly, actual results may differ materially from those currently anticipated in such statements. Factors that could cause actual results to differ materially from those in forward looking statements include continued availability of capital and financing and general economic, market or business conditions, the loss of key directors, employees, advisors or consultants, equipment failures, litigation, competition, fees charged by service providers and failure of counterparties to perform their contractual obligations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FEATURE: Monarques Gold (TSX-V: MQR) Flagship Croinor Gold Mine Has Great Potential To Become A Producer $MQR.ca

Posted by AGORACOM-JC at 10:11 AM on Thursday, June 29th, 2017

Monarquesgold hub large

Why Monarques Gold?

  • Flagship Croinor Gold Mine Has Great Potential To Become A Producer
  • Company Is Well Financed, Including $9 Million In Credits From Quebec Government
  • Recently acquired 750 ton-per-day Beacon mill
  • Major Shareholders include: Rob McEwen and Nemaska Lithium

Croinor Gold Property

Flagship project at the prefeasibility stage

  • 100% interest in the Croinor Gold property, a gold mine project that is currently at the prefeasibility stage
  • Property consists of one mining lease and two non-contiguous blocks of claims for a total of 335 claims over a 151 km² area. A 1.5% NSR is applicable on the mining lease and only 44 claims.
  • Drilling program will test a diorite-hosted gold-bearing zone that returned grades of up to 38.7 g/t Au over 3.8 metres in historical drilling (see release)

WATCH OUR CORPORATE VIDEO

Check Out Croinor Gold
Prefeasability Study

Simkar Gold Property

NI 43-101 Gold Resource 20 km from Val-d’Or

  • 100% interest in the Simkar Gold property
  • located 20 kilometres east of Val-d’Or, in the heart of the Abitibi Greenstone Belt.
  • Comprised of two mining concessions and 15 claims covering an area of 5 km², and is subject to a 1.5% NSR.
  • NI 43-101 (click here)

The Simkar Gold property is the result of a merger of the Simkar and Texsol properties. The transaction was announced by way of press release on June 26, 2014.

Regcourt Gold Property – Val d’Or

  • 100% interest in the Regcourt Gold property
  • Property is located at the eastern end of the Val-d’Or gold mining camp, some 30 km east of Val-d’Or, and is easily accessible via Route 117.
  • Consists of 94 claims covering an area of 38 km2 near the centre of the western border of Vauquelin Township
  • Property is subject to a 1.5% and 2.5 % NSR.

 

12 Month Stock Chart

PyroGenesis Comments on Unusual Stock Trading Activity; Provides Guidance on Q2-2017 Results $PYR.ca

Posted by AGORACOM-JC at 8:45 AM on Thursday, June 29th, 2017

Pyr header 1

“Recent market trading activities may well be difficult to understand, not only from the Company’s perspective, but by shareholders and market players alike,” said P. Peter Pascali, President and CEO of PyroGenesis. “We wish to reassure all of our stakeholders and market participants that the fundamentals of PyroGenesis, in terms of activities previously reported on, as well as the progress being made thereon, are not only sound but are moving forward at a rapid pace.

MONTREAL, QUEBEC–(June 29, 2017) – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX VENTURE:PYR)(OTCQB:PYRNF), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and plasma torch products, announces today that it has observed significant and unusual trading in its common stock in recent days. Management knows of no reason that would give rise to such unusual trading and has no significant information to disclose which could lead to such activity. The Company is current on all its regular quarterly filings, has made (in advance) its second quarter interest payment due under its previously completed convertible debenture, and plans to report its second quarter results in August as required by the TSX Venture Exchange.

“Recent market trading activities may well be difficult to understand, not only from the Company’s perspective, but by shareholders and market players alike,” said P. Peter Pascali, President and CEO of PyroGenesis. “We wish to reassure all of our stakeholders and market participants that the fundamentals of PyroGenesis, in terms of activities previously reported on, as well as the progress being made thereon, are not only sound but are moving forward at a rapid pace. Although we have not provided market guidance in the past, we believe, under the circumstances, that it would be most prudent to do so. As such, we can say with certainty that our Q2-2017 results will be significantly better than that posted for the same period in 2016, and in all likelihood will be cash flow positive from an EBITDA (adjusted) basis as well; which will make it the 3rd of the past four quarters that the Company has been cash flow positive on that basis. In short, we have never been better positioned and we are extremely confident with the progress being made across all of our business lines.”

Additional information on the Company is available on SEDAR at www.sedar.com.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc. is the world leader in the design, development, manufacture and commercialization of advanced plasma processes. PyroGenesis provides engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Its core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Its operations are ISO 9001:2008 certified, and have been ISO certified since 1997. PyroGenesis is a publicly-traded Canadian company on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace (Ticker Symbol: PYRNF). For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTC Markets Group Inc. accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

Rodayna Kafal
VP, Investor Relations and Communications
(514) 937-0002
ir@pyrogenesis.com or rkafal@pyrogenesis.com
www.pyrogenesis.com

GGX Gold Announces Purchase of Proprietary Mobile Processing Plant for Gold Drop Property Historic Gold Mining Camp Greenwood BC $GGX.ca

Posted by AGORACOM-JC at 8:27 AM on Thursday, June 29th, 2017

  • Amended terms of its asset purchase agreement with Munroe Materials Inc. a private Manitoba corporation
  • Assets to be acquired from Munroe include a processing plant, equipment and related assets

GGX Gold Announces Purchase of Proprietary Mobile Processing Plant for Gold Drop Property Historic Gold Mining Camp Greenwood BC

Vancouver, British Columbia (FSCwire)GGX Gold Corp. (TSXV: GGX) (the “Company” or “GGX”) is pleased to announce amended terms of its asset purchase agreement (the “Amended Agreement”) with Munroe Materials Inc. (“Munroe”), a private Manitoba corporation.

To view the graphic in its original size, please click her

Pursuant to the Amended Agreement, Munroe and the Company agreed to reduce the purchase price of the Assets (defined below) from $250,000 to $200,000 and for the remaining $150,000 due ($50,000 paid to date) under the Amended Agreement to be paid by the Company through the issuance of 750,000 common shares at a deemed price of $0.20 per common share.

Assets to be Acquired

The assets to be acquired from Munroe include a processing plant, equipment and related assets (the “Assets”).  The equipment consists of a proprietary mobile ore sampler involving a unique process for onsite collecting, reducing, and concentrating minerals from host rock. This mobile platform enables the miner to perform bulk sample testing directly at the mine site, or on a promising mineralized outcrop. The system can be modulated for speed and can process up to 5 tons of ore per hour. This process curtails the need for a tailings pond as all water is recycled.

GGX intends to use the Assets for exploration on its Gold Drop Property to help in determining the economic potential of multiple quartz veins throughout the property.

To view the graphic in its original size, please click here

About Munroe Materials Inc.

Munroe is a private Manitoba company in the business of developing innovative mineral processing plants. Munroe has certain intellectual property related to the processing of ore. GGX and Munroe intend to explore the possibility of patenting this process.

GGX expects to complete the purchase of the Assets on or before the end of July 2017. Further details of the Assets will be provided when GGX completes such purchase. There can be no assurance that the acquisition of the Assets will be completed as proposed or at all.  See the Company’s news release on March 27, 2017 for further details.

On Behalf of the Board of Directors

Barry Brown, Director

604-488-3900

Forward Looking Information

This news release includes certain statements that constitute “forward-looking information” within the meaning of applicable securities law, including without limitation, the Company’s information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed transactions. Forward-looking statements address future events and conditions and are necessarily based upon a number of estimates and assumptions. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Forward-looking statement are necessarily based upon several factors that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements express or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of gold and other metals, anticipated costs and the ability to achieve goals, and the Company will be able to obtain required licenses and permits. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks including that resource exploration and development is a speculative business; that environmental laws and regulations may become more onerous; that the Company may not be able to raise additional funds when necessary; fluctuating prices of metals; the possibility that future exploration, development or mining results will not be consistent with the Company’s expectations; operating hazards and risks; and competition. There can be no assurance that economic resources will be discovered or developed at the Gold Drop Property. Accordingly, actual results may differ materially from those currently anticipated in such statements. Factors that could cause actual results to differ materially from those in forward looking statements include continued availability of capital and financing and general economic, market or business conditions, the loss of key directors, employees, advisors or consultants, equipment failures, litigation, competition, fees charged by service providers and failure of counterparties to perform their contractual obligations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tetra Bio-Pharma Expands Focus of Commercialization Activities into the Lucrative Veterinary Market $TPB.ca

Posted by AGORACOM-JC at 8:27 AM on Wednesday, June 28th, 2017

Tbp large

  • Commercializing novel cannabinoid based formulations for the treatment of pet conditions
  • Tetra will adopt a similar regulatory approach of transparency and collaboration with the veterinary drug authorities

OTTAWA, ONTARIO–(June 28, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announced today that it will also commercialize novel cannabinoid based formulations for the treatment of pet conditions.

Over the last year, Tetra demonstrated its leadership in the development of human prescription cannabinoid drugs and will use the same strategy to become a leader in the field of veterinary cannabinoid drug products. Tetra will adopt a similar regulatory approach of transparency and collaboration with the veterinary drug authorities. In fact, Tetra is well suited to tackle the veterinary drug market since the ACMPR was created to allow human patient’s access to medical marijuana and does not provide any measures to allow testing of cannabis or cannabis derived products in pets.

According to a USA Federal Trade Commission May 2015 report, in 2014, Americans spent approximately $58 billion on their pets, including medications. This number more than doubled since 2001. This market is expected to enjoy excellent growth over the next decade as new therapies provide better and more tolerable treatment for pets. According to Andre Rancourt, CEO of Tetra Bio-Pharma, “After carefully studying the veterinary pet market and potential partnerships, the company decided to expand its development activities in order to tap into this lucrative market. In addition, Tetra is very fortunate to have Dr. Chamberland who has considerable experience navigating the regulatory affairs in the veterinary industry.”

Tetra had announced the successful completion of several corporate milestones associated with the development of its prescription drug products. These announcements lead to discussions with veterinary specialists who expressed the need for novel cannabinoid therapies for pets.

Tetra will create a Veterinary Advisory board consisting of veterinary specialists in the fields of ophthalmology, oncology and pain. This board of veterinary experts will help guide the development to ensure that the products target unmet veterinary needs for domestic animals. Tetra will use the veterinary drug development program to expand its potential revenues from the sales of a drug product in both the human and pet drug markets. The corporation will also establish partnerships with pharmaceutical companies specialized in the sale and distribution of veterinary products.

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(OTCQB:TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
(514) 360-8040 Ext. 203
edward@tetrabiopharma.com

New Age Metals Appoints Mr. Ron Hieber from Advisory to Director $NAM.ca

Posted by AGORACOM-JC at 9:42 AM on Tuesday, June 27th, 2017

New age large

  • Appointed Mr. Ron Hieber from the Advisory Board to the Board of Directors.

June 27th, 2017 / Vancouver, Canada – New Age Metals Inc. (TSX.V: NAM; OTCQB: PAWEF; FSE: P7J.F). The Company is pleased to appoint Mr. Ron Hieber from the Advisory Board to the Board of Directors.

The Chairman and CEO Harry Barr stated; “The Board of Directors and management are very privileged to have Ron Hieber join the Board of Directors from the Advisory Board. His reputation in the PGM and worldwide mining industry is surpassed by few. As you can see from his bio below, Ron is an excellent fit to the Board of Directors of NAM and we look forward to our ongoing relationship with Ron that has extended for over 17 years”.

Mr. Hieber is an Internationally Recognized Expert, in Platinum Group Metals, and was Head of Worldwide Exploration, for Anglo Platinum, the world’s largest Platinum producer. He is a geology graduate of Rhodes University, South Africa, with high school education having been completed in Zimbabwe, in 1968. He began his career with Anglo American Platinum, on the company’s Platinum mines in Rustenburg, followed by service on the mines in other Bushveld Complex areas, becoming Chief Geologist at Rustenburg in 1981.
In 1986, he was appointed to the corporate office as head of all Anglo Platinum’s mining geology and exploration functions, which remained part of his responsibilities until he retired from Anglo Platinum at 58, in 2009. During his service with Anglo, Ron was made a Divisional Director and the Group’s Survey, Ventilation, Rock Engineering and Strategic Planning functions were added to his Geological responsibilities. From the time of his appointment at Corporate, he contributed significantly to the accumulation, retention and management of Anglo Platinum’s mineral rights portfolio, on the Bushveld Complex and Great Dyke, whilst also directing worldwide PGM Exploration Programs for Anglo Platinum, in Australia, China, Canada, Russia and Brazil. This included heading-up the River Valley Option/Joint Venture for Anglo Platinum, from Discovery, in 2000, with Pacific North West Capital, now New Age Metals. At the time he retired, he was a Director of several Anglo Platinum subsidiaries, including Unki Platinum Ltd. (Zimbabwe) and Rustenburg Platinum Mines Ltd. From 2009, Ron worked as Executive Director: Business Development for Kameni Ltd., which had PGM interests, in the Eastern Bushveld and Zimbabwe. After selling its projects, Kameni closed and Mr. Hieber now runs his own company, with interests in South African and Zimbabwean Gold projects.

ABOUT NAM’S PGM DIVISION

NAM’s flagship project is its 100% owned River Valley PGM Project (NAM Website – River Valley Project) in the Sudbury Mining District of Northern Ontario (100 km east of Sudbury, Ontario). Presently the River Valley Project is Canada’s largest primary undeveloped PGM deposit with Measured + Indicated resources of 91 million tonnes @ 0.58 g/t* Palladium, 0.22 g/t Platinum, 0.04 g/t Gold, at a cut-off grade of 0.8 g/t for a PdEq of 2,463,000 ounces PGM plus Gold. The River Valley PGM-Copper-Nickel Sulphide mineralized zones remain open to expansion, and geophysics currently completed and drilling to commence mid July 2017 as part of our ongoing continued exploration.

In 2016, the company acquired the River Valley extension property from Mustang Minerals which added approximately 4kms to the project’s mineralized strike length.

ABOUT NAM’S LITHIUM DIVISION

The Company has several Hard Rock Lithium Projects in the Winnipeg River Pegmatite Field, located in SE Manitoba. This Pegmatite Field hosts the world class Tanco Pegmatite that has been mined for Tantalum, Cesium and Spodumene (one of the primary Lithium ore minerals) in varying capacities, since 1969. Today, the Tanco Mine is focused on the mining of Pollucite (primary Cesium ore) and the production of Cesium Formate, a completion drilling fluid for the petroleum industry. NAM’s Lithium Projects are strategically situated in this prolific Pegmatite Field. Presently, NAM is the largest mineral claim holder in the Winnipeg River Pegmatite Field and is seeking JV partners to further develop the company’s Li division.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

HPQ Announces AGM Results, Up Date On Purity Testing And Launches “CEO Verified” Discussion Forum On AGORACOM $HPQ.ca

Posted by AGORACOM-JC at 3:48 PM on Friday, June 23rd, 2017

Hpq large

  • As a result of review, HPQ and PyroGenesis have now approved a new testing protocol to be used going forward for the Silicon Metal produce by the PUREVAP™ QRR
  • New testing protocol will first assess the homogeneity of the silicon phase by Scanning Electron Microscope – Energy Dispersive Spectroscopy (SEM-EDS) in back scattering mode before any destructives test are completed

HPQ Silicon Resources Inc (“HPQ”) (TSX Venture: HPQ) is pleased to report that all matters submitted to the shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular, were approved during the Annual General and Special Meeting of the shareholders held on Wednesday June 21, 2017 in Montreal (the “AGM”).

Over 72,619,168 shares representing 42.97% of the 168,987,616 shares issued and outstanding as at the record date were voted.

RESULTS OF THE AGM VOTES

The following persons were re-elected as directors of the Corporation, to hold office until the next Annual Meeting or until their successors are elected or appointed:

With 99.85% of the vote in favor, Raymond Chabot Grant Thornton, LLP, chartered accountants, were appointed auditors of the Corporation for the ensuing year.

Bernard Tourillon, Chairman and CEO of HPQ stated, “We extremely pleased with obtaining 42.97% shareholder participation, up from 42.31% last year. Such a strong vote of confidence for the board and management team, during this transition year bodes very well for the future.

UPDATE ON ONGOING SILICON METAL PURITY TESTING

On June 2, 2017, PyroGenesis Canada Inc (“PyroGenesis”) submitted to HPQ a Technical Memo entitled “Analysis options for characterization of silicon products for PUREVAPtm”, as mention in our May 16, 2017 PR.

As a result of this review, HPQ and PyroGenesis have now approved a new testing protocol to be used going forward for the Silicon Metal produce by the PUREVAP™ QRR.  The new testing protocol will first assess the homogeneity of the silicon phase by Scanning Electron Microscope – Energy Dispersive Spectroscopy (SEM-EDS) in back scattering mode before any destructives test are completed.  While the addition of this step increases the time before we get any results above 3N+ purity, this step was deemed critical in assessing sample purity level.

Once these results have been analyzed, the material will be sent to a third-party laboratory for either Glow Discharge Mass Spectrometry (GDMS) testing or Inductively-Coupled-Plasma Mass-Spectrometry (ICP – MS) testing and in some case even both.

Testing for the purity of some of the material produced using lower quality feedstock (test #54 to #74) and some material produced using high Purity Quartz (99.5% SiO2) (Test #75 and above), but still using the old set-up of the PUREVAP™ QRR,have begun this week.

Bernard J. Tourillon, Chairman and CEO of HPQ Silicon stated, “Building on our success to date, the coming months should allow us to continue to make improvements to our scaling up program, while simultaneously testing for the best and greenest pathway to produce Solar Grade Silicon Metal at lab scale, prior to start-up of the Pilot plant scheduled for 2018.”

LAUNCH OF HPQ SILICON “CEO VERIFIED” DISCUSSION FORUM

AGORACOM has launched “CEO Verified” Discussion Forums, the first ever verification of small cap executive posts on a finance platform, as a superior alternative to general social media sites.  For the first time ever, small cap CEO’s and other company officials can use AGORACOM discussion forums as their main social media platform to post comments and interact with both shareholders and the broader investment community in a fully moderated and verified forum. Posts to AGORACOM are shareable on Twitter, Facebook and LinkedIn so that companies can continue to maintain a presence on key social media sites.

“CEO Verified” Discussion Forums represents an industry first, as small cap CEO’s and officials simply could not communicate with shareholders in any finance community due to lack of verification and the risk of impersonation leading to catastrophic consequences.  AGORACOM “CEO Verified” Discussion Forums will create incredible levels of engagement between companies and investors that have long desired civilized, constructive and factual conversation, with no limitations to character limits and use of multi-media.

The HPQ Silicon CEO Verified Discussion Forum can be found at https://agoracom.com/ir/HPQ-SiliconResources/forums/discussion.  There are no log-in requirements for investors to read posts.  Those wishing to post questions, comments and interact with HPQ Silicon management can quickly log-in using their Facebook or LinkedIn accounts, or create a new user account in under 1-minute.

Verified HPQ Silicon officials will be:

  • Bernard Tourillon – Chairman and CEO
  • Patrick Levasseur – President and COO

Bernard Tourillon stated, “I encourage all of our investors to join our CEO Verified Discussion Forum and create great, vibrant, factual and constructive discussion for the long term benefit of everyone. This is a great concept that will replace our individual conversations with retail investors. This new format creates 100% transparency because all shareholders will see the questions and answers, as well as, making us more efficient by eliminating repetition. As such, it is a far superior format that we will fully embrace.”

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer.

Our business model is focused on developing a disruptive High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated High Value Silicon Metal and Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line.

Disclaimers:

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

For further information contact

 

Bernard J. Tourillon, Chairman and CEOTel (514) 907-1011 Patrick Levasseur, President and COOTel: (514) 262-9239 www.HPQSilicon.com

INTERVIEW: Harry Barr Discusses Canada’s Largest Primary PGM Deposit + Lithium Initiatives $NAM.ca

Posted by AGORACOM-JC at 12:45 PM on Friday, June 23rd, 2017